|
41 Companies |
|
29 Products |
|
29 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
854 News |
|
| «12...567891011121314151617» |
- Eurartesim (dihydroartemisinin/piperaquine) / Medicines for Malaria Venture, Leadiant Biosci
Enrollment open: STOP MiP KENYA: Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya (clinicaltrials.gov) - Sep 9, 2012
P4, N=1554, Recruiting, Sponsor: Kenya Medical Research Institute
Not yet recruiting --> Recruiting
- chloroquine phosphate / Generic mfg., sulfadoxine/pyrimethamine / Generic mfg., artemether/lumefantrine / Generic mfg.
Trial completion: Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines (clinicaltrials.gov) - Sep 9, 2012
P=N/A, N=560, Completed, Sponsor: Centers for Disease Control and Prevention
Not yet recruiting --> Recruiting Recruiting --> Completed
- chloroquine phosphate / Generic mfg., sulfadoxine/pyrimethamine / Generic mfg.
Trial completion, Combination therapy: Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy (clinicaltrials.gov) - Sep 9, 2012
P4, N=1614, Completed, Sponsor: Centers for Disease Control and Prevention
Recruiting --> Completed Recruiting --> Completed
- Trial completion: Efficacy and Effectiveness of Combined Therapy for Uncomplicated Malaria Treatment in Peru (clinicaltrials.gov) - Sep 9, 2012
P4, N=208, Completed, Sponsor: Centers for Disease Control and Prevention
Recruiting --> Completed Recruiting --> Completed
- sulfadoxine/pyrimethamine / Generic mfg.
Trial completion, Combination therapy: Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria (clinicaltrials.gov) - Sep 9, 2012
P4, N=390, Completed, Sponsor: Centers for Disease Control and Prevention
Recruiting --> Completed Recruiting --> Completed
- Clinical: Improving Blood Safety and HIV Testing in Brazil (clinicaltrials.gov) - Sep 6, 2012
P=N/A, N=12000, Recruiting, Sponsor: Blood Systems Research Institute
- | New P4 trial: Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease (clinicaltrials.gov) - Sep 3, 2012
P4, N=220, Active, not recruiting, Sponsor: Drugs for Neglected Diseases
- | Trial completion: A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model (clinicaltrials.gov) - Sep 2, 2012
P1/2, N=36, Completed, Sponsor: Crucell Holland BV
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment closed: Pop PK Chagast: Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease (clinicaltrials.gov) - Aug 26, 2012
P4, N=80, Active, not recruiting, Sponsor: Drugs for Neglected Diseases
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Eurartesim (dihydroartemisinin/piperaquine) / Medicines for Malaria Venture, Leadiant Biosci
New P4 trial: STOP MiP KENYA: Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya (clinicaltrials.gov) - Aug 19, 2012
P4, N=1554, Recruiting, Sponsor: Kenya Medical Research Institute
- New P1 trial, Viral vector: Adjuvanting Viral Vectored Malaria Vaccines With Matrix M (clinicaltrials.gov) - Aug 19, 2012
P1, N=22, Recruiting, Sponsor: University of Oxford
- | New P2 trial: Efficacy of Malaria Vaccines in Kenyan Adults (clinicaltrials.gov) - Aug 14, 2012
P2, N=120, Completed, Sponsor: University of Oxford
- || Trial initiation date: Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing (clinicaltrials.gov) - Aug 9, 2012
P=N/A, N=532, Completed, Sponsor: Gen-Probe, Incorporated
Recruiting --> Active, not recruiting Initiation date: Jul 2011 --> Aug 2012
- Trial completion: An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh (clinicaltrials.gov) - Aug 9, 2012
P=N/A, N=120, Completed, Sponsor: PATH
Initiation date: Jul 2011 --> Aug 2012 Active, not recruiting --> Completed
- | Lenocta (sodium stibogluconate) / VioQuest
New P4 trial: Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India (clinicaltrials.gov) - Aug 7, 2012
P4, N=100, Completed, Sponsor: Sarder Patel Medical College
- levetiracetam / Generic mfg.
New P1/2 trial: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (clinicaltrials.gov) - Aug 7, 2012
P1/2, N=7, Completed, Sponsor: Michigan State University
- Mefliam Plus (artesunate/mefloquine) / Cipla, Oswaldo Cruz Foundation, DNDi
Combination therapy: Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand (clinicaltrials.gov) - Aug 5, 2012
P=N/A, N=13, Completed, Sponsor: Armed Forces Research Institute of Medical Sciences, Thailand
- | New P2 trial: Efficacy of Candidate Malaria Vaccines in Senegalese Adults (clinicaltrials.gov) - Aug 5, 2012
P2, N=120, Completed, Sponsor: University of Oxford
- | Enrollment change: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Jul 30, 2012
P3, N=3600, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Active, not recruiting --> Completed N=18000 --> 3600
- Clinical: Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail Sector (clinicaltrials.gov) - Jul 26, 2012
P=N/A, N=2800, Completed, Sponsor: Harvard School of Public Health
- | amodiaquine hydrochloride / Generic mfg., sulfadoxine/pyrimethamine / Generic mfg., artemether/lumefantrine / Generic mfg.
New P4 trial, Combination therapy: Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana (clinicaltrials.gov) - Jul 25, 2012
P4, N=2400, Recruiting, Sponsor: Centre for Global Health Research, Ghana
- Enrollment open: Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria (clinicaltrials.gov) - Jul 23, 2012
P=N/A, N=50, Recruiting, Sponsor: University of Oxford
N=18000 --> 3600 Not yet recruiting --> Recruiting
- chloroquine phosphate / Generic mfg.
Trial completion: EHMI9: Experimental Human Malaria Infection After Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=25, Completed, Sponsor: Radboud University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Lenocta (sodium stibogluconate) / VioQuest
Trial completion: A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis (clinicaltrials.gov) - Jul 22, 2012
P2, N=45, Completed, Sponsor: Infectious Disease Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || New P3 trial: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Jul 17, 2012
P3, N=3600, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
- || chloroquine phosphate / Generic mfg., primaquine / Generic mfg.
New P3 trial: Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD) (clinicaltrials.gov) - Jul 11, 2012
P3, N=900, Recruiting, Sponsor: University of Oxford
- efavirenz / Generic mfg., artemether/lumefantrine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Trial completion: Drug Interaction Study Between Antimalarial and Anti-HIV Medications (clinicaltrials.gov) - Jul 11, 2012
P1, N=33, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Recruiting --> Completed
- sulfadoxine/pyrimethamine / Generic mfg.
Trial completion: Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria (clinicaltrials.gov) - Jul 10, 2012
P=N/A, N=100, Completed, Sponsor: University of Oxford
Recruiting --> Completed Recruiting --> Completed
- | New P1/2 trial: A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso (clinicaltrials.gov) - Jul 5, 2012
P1/2, N=700, Recruiting, Sponsor: University of Oxford
- artemether/lumefantrine / Generic mfg.
New P3 trial: Artemether/Lumefantrine and Vivax Malaria (clinicaltrials.gov) - Jun 20, 2012
P3, N=38, Completed, Sponsor: University of Khartoum
- | New P1 trial: Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults (clinicaltrials.gov) - Jun 19, 2012
P1, N=30, Completed, Sponsor: Sanaria Inc.
- Trial initiation date, Combination therapy: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis (clinicaltrials.gov) - Jun 18, 2012
P0, N=30, Completed, Sponsor: Tehran University of Medical Sciences
Recruiting --> Completed Initiation date: Dec 2009 --> Mar 2011
- Clinical: Malaria Prevention Cambodia (clinicaltrials.gov) - Jun 18, 2012
P=N/A, N=231, Suspended, Sponsor: Armed Forces Research Institute of Medical Sciences, Thailand
- New P1/2 trial, Viral vector: A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates (clinicaltrials.gov) - Jun 18, 2012
P1/2, N=30, Completed, Sponsor: University of Oxford
- Trial completion, Combination therapy: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis (clinicaltrials.gov) - Jun 18, 2012
P0, N=30, Completed, Sponsor: Tehran University of Medical Sciences
Initiation date: Dec 2009 --> Mar 2011 Recruiting --> Completed
- Trial completion: Clinical Trial for the Development of a Safe Malaria Challenge Model That Can be Reproduced in Humans (clinicaltrials.gov) - Jun 18, 2012
P1, N=12, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas (clinicaltrials.gov) - Jun 14, 2012
P1, N=30, Completed, Sponsor: University of Oxford
Active, not recruiting --> Completed Recruiting --> Completed
- sulfadoxine/pyrimethamine / Generic mfg.
Trial completion: Impact of IPT With Sulfadoxin Pyrimetamin on Pregnant Women and Their Babies Outcomes in Peri-urban Areas of Bobo-Dioulasso(Burkina Faso) (clinicaltrials.gov) - Jun 14, 2012
P=N/A, N=772, Completed, Sponsor: Universit
Recruiting --> Completed Recruiting --> Completed
- artemether/lumefantrine / Generic mfg.
New P2/3 trial: Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg (clinicaltrials.gov) - Jun 12, 2012
P2/3, N=40, Recruiting, Sponsor: Novartis Pharmaceuticals
- chloroquine phosphate / Generic mfg., primaquine / Generic mfg.
Trial completion: PQCQ: Pharmacokinetic Study of Primaquine and Chloroquine in Healthy Subjects (clinicaltrials.gov) - Jun 12, 2012
P1, N=16, Completed, Sponsor: University of Oxford
Recruiting --> Completed Recruiting --> Completed
- Trial completion, Adherence: TACT: A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria Tests (clinicaltrials.gov) - Jun 10, 2012
P=N/A, N=1152, Completed, Sponsor: London School of Hygiene and Tropical Medicine
Recruiting --> Completed Not yet recruiting --> Completed
- mefloquine / Generic mfg.
New P1 trial: Safety, Tolerability & Pharmacokinetics (PK) of Co-administered Single Doses of OZ439 and Mefloquine (MQ) in Healthy Volunteers (clinicaltrials.gov) - Jun 7, 2012
P1, N=24, Terminated, Sponsor: Medicines for Malaria Venture
- Enrollment change: Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection (clinicaltrials.gov) - Jun 3, 2012
P2a, N=80, Completed, Sponsor: Medicines for Malaria Venture
Not yet recruiting --> Completed N=60 --> 80
- Trial completion: Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection (clinicaltrials.gov) - Jun 3, 2012
P2a, N=80, Completed, Sponsor: Medicines for Malaria Venture
N=60 --> 80 Recruiting --> Completed
- Trial completion: Impact of Malaria Prevention on Health and Education in Kenyan Schoolchildren (clinicaltrials.gov) - May 31, 2012
P=N/A, N=5177, Completed, Sponsor: London School of Hygiene and Tropical Medicine
Recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Mosquirix (RTS,S) / GSK
Trial completion, Head-to-Head: Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children (clinicaltrials.gov) - May 23, 2012
P3, N=327, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- trimethoprim/sulfamethoxazole / Generic mfg.
Trial initiation date: Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya (clinicaltrials.gov) - May 21, 2012
P=N/A, N=500, Completed, Sponsor: University of Washington
Active, not recruiting --> Completed Initiation date: Nov 2011 --> Feb 2012
- | artemether/lumefantrine / Generic mfg.
New P1/2 trial, Combination therapy: Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission (clinicaltrials.gov) - May 20, 2012
P1/2, N=120, Completed, Sponsor: London School of Hygiene and Tropical Medicine
- Trial completion: EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune Adults (clinicaltrials.gov) - May 9, 2012
P1, N=60, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Initiation date: Nov 2011 --> Feb 2012 Active, not recruiting --> Completed
- Trial completion: Malaria Challenge With NF54 Strain (clinicaltrials.gov) - May 9, 2012
P1, N=37, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed